HLA in primary open-angle glaucoma

International Archives of Allergy and Applied Immunology
|January 1, 1977
PubMed

Insights

Certain human leukocyte antigen (HLA) types are significantly more common in primary open-angle glaucoma (POAG) patients. This finding suggests a potential genetic link between specific HLA antigens and POAG development.

Area of Science:

  • Immunogenetics
  • Ophthalmology
  • Human Leukocyte Antigen (HLA) system

Background:

  • Primary open-angle glaucoma (POAG) is a leading cause of irreversible blindness worldwide.
  • The genetic factors influencing POAG susceptibility are not fully understood.
  • The human leukocyte antigen (HLA) system plays a crucial role in immune responses and has been implicated in various autoimmune and inflammatory diseases.

Purpose of the Study:

  • To investigate the association between specific HLA antigen profiles and the prevalence of primary open-angle glaucoma (POAG) in Caucasian individuals.
  • To determine if certain HLA alleles are significantly more or less common in POAG patients compared to a control group.

Main Methods:

  • Histocompatibility antigen typing was performed on 50 Caucasian patients diagnosed with POAG.
  • A control group of 50 Caucasian subjects with ocular hypertension but no glaucoma was included for comparison.
  • Statistical analysis was used to compare the frequencies of specific HLA antigens and their combinations between the POAG and control groups.

Main Results:

  • Significantly higher prevalences of HLA-A3 (46%), HLA-B7 (52%), and HLA-B12 (50%) were observed in POAG patients compared to controls (p < 0.01).
  • The combined presence of HLA-B7 or HLA-B12 was found in 88% of POAG patients, a significantly higher frequency than in controls (p < 0.0005).
  • Specific HLA combinations, including HLA-A3-B7 and HLA-A3-B12, were also significantly more prevalent in the POAG group (p < 0.005).
  • Conversely, HLA-BW35 was found to be significantly less frequent in Caucasian POAG patients (8%) compared to controls (32%; p < 0.01).

Conclusions:

  • The study identifies a significant association between specific HLA antigen profiles, particularly HLA-A3, HLA-B7, and HLA-B12, and an increased risk of primary open-angle glaucoma in Caucasians.
  • The deficit of HLA-BW35 in POAG patients suggests a potential protective effect or a complex interaction within the HLA system.
  • These findings highlight the potential role of immunogenetic factors in the pathogenesis of POAG and warrant further investigation.

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...